Loading…
Based on limited metadata, Phoenix Biotechnology, Inc. received an FDA Warning Letter on December 15, 2020, regarding drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning was issued under FDA's drug regulatory authority, though the specific issuing office is not identified in this metadata. Additional documentation would be needed to identify the particular manufacturing, quality, or compliance deficiencies that prompted the agency's action.